The expert advisory panel must—
(a) at the request of the chief executive—(i) provide advice, and make recommendations, to the chief executive regarding applications for approvals; and(ii) make recommendations about current or proposed research related to the therapeutic use of cannabis products; and
(b) undertake ongoing monitoring of—(i) the use of medicinal cannabis in Queensland; and(ii) research related to the therapeutic use of cannabis products; and(iii) advancements and developments in the field.